---
figid: PMC4768188__WJG-22-2415-g001
figtitle: Fiblobrast growth factor structure and signaling network
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4768188
filename: WJG-22-2415-g001.jpg
figlink: /pmc/articles/PMC4768188/figure/F1/
number: F1
caption: 'The fiblobrast growth factor structure and signaling network. The Fibroblast
  growth factor (FGF)-FGFR complex consists of two receptor molecules, two FGFs, and
  a heparan sulfate proteoglycan (HSPG). The HSPG stabilizes and sequesters the FGFs.
  The FGFR comprises three extracellular Ig-like domains (D1-3), a transmembrane helix,
  and an intracellular split tyrosine kinase domain. D1 and D3 are separated by an
  acidic box. Ligand specificity of FGFR is regulated by alternative splicing within
  the C-terminal half of the third Ig loop (D3) in the ligand binding domain. Ligand
  binding and FGFR dimerization trigger the kinase domain phosphorylation, which leads
  to the docking of adapter residues and the activation of downstream pathways. Ligand-stimulated
  FGFRs phosphorylate the FGFR-associated cytosolic docking protein, FRS2. FRS2 activates
  SOS and GRB2, which in turn activate the Ras-Raf-MAPK pathway. A different complex
  involves GAB1, which activates the PI3K-Akt pathway. PLCγ hydrolyzes PIP2 to IP3
  and DAG. PIP3 produces calcium. DAG also activates PKC, which results in the activation
  of the MAPK pathway by phosphorylating Raf. HSPG: Heparan sulfate proteoglycan;
  DAG: Diacylglycerol; FRS2α: FGFR substrate 2α; GRB2: Growth factor receptor-bound
  2; IP3: Inositol triphosphate; PI3K: Phosphoinositide 3-kinase; PIP: 2-phosphatidylinositol-4,5-biphosphate;
  PKC: Protein kinase C; SOS: Son of sevenless; GAB1: GRB2-associated binding protein
  1; PLCγ: Phospholipase Cγ.'
papertitle: Fibroblast growth factor receptor signaling as therapeutic targets in
  gastric cancer.
reftext: Masakazu Yashiro, et al. World J Gastroenterol. 2016 Feb 28;22(8):2415-2423.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9172258
figid_alias: PMC4768188__F1
figtype: Figure
redirect_from: /figures/PMC4768188__F1
ndex: 0e884b97-deed-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4768188__WJG-22-2415-g001.html
  '@type': Dataset
  description: 'The fiblobrast growth factor structure and signaling network. The
    Fibroblast growth factor (FGF)-FGFR complex consists of two receptor molecules,
    two FGFs, and a heparan sulfate proteoglycan (HSPG). The HSPG stabilizes and sequesters
    the FGFs. The FGFR comprises three extracellular Ig-like domains (D1-3), a transmembrane
    helix, and an intracellular split tyrosine kinase domain. D1 and D3 are separated
    by an acidic box. Ligand specificity of FGFR is regulated by alternative splicing
    within the C-terminal half of the third Ig loop (D3) in the ligand binding domain.
    Ligand binding and FGFR dimerization trigger the kinase domain phosphorylation,
    which leads to the docking of adapter residues and the activation of downstream
    pathways. Ligand-stimulated FGFRs phosphorylate the FGFR-associated cytosolic
    docking protein, FRS2. FRS2 activates SOS and GRB2, which in turn activate the
    Ras-Raf-MAPK pathway. A different complex involves GAB1, which activates the PI3K-Akt
    pathway. PLCγ hydrolyzes PIP2 to IP3 and DAG. PIP3 produces calcium. DAG also
    activates PKC, which results in the activation of the MAPK pathway by phosphorylating
    Raf. HSPG: Heparan sulfate proteoglycan; DAG: Diacylglycerol; FRS2α: FGFR substrate
    2α; GRB2: Growth factor receptor-bound 2; IP3: Inositol triphosphate; PI3K: Phosphoinositide
    3-kinase; PIP: 2-phosphatidylinositol-4,5-biphosphate; PKC: Protein kinase C;
    SOS: Son of sevenless; GAB1: GRB2-associated binding protein 1; PLCγ: Phospholipase
    Cγ.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Gclm
  - btl
  - htl
  - bnl
  - drk
  - Sos
  - ras
  - Ras64B
  - Ras85D
  - Stat92E
  - Raf
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - sl
  - Akt
  - Dsor1
  - Mtk
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Erk7
  - rl
  - ca
  - HSPG2
  - SDC2
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FRS2
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - A1BG
  - KRAS
  - HRAS
  - NRAS
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PLCG1
  - PLCG2
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - EPHB2
  - MAPK1
  - MAPK3
  - Tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
